A if for Agilent, B is for Boulder, C is for Nucleic Acid

Did you know that Agilent Technologies (NYSE: A) provides bio-analytical and electronic solutions to a variety of industries; the company's bio-analytical measurement business segment provides application-focused solutions that include instruments, software, consumables, and services that enable their customers to identify, quantify, and analyze physical and biological properties. Its product categories include gas chromatography, liquid chromatography, mass spectrometry, microfluidics, microarrays, atomic force microscopy, PCR instrumentation, software and informatics, and related bioreagents, as well as consumables and services.

A portion of that bioreagent business sits squarely in the middle of Boulder, as a result of the 2006 acquisition of SynPro, where the focus is on large-scale nucleic acid synthesis and purification for pharmaceutical ingredient manufacturing. Now the $5B a year Agilent plans to grow the Boulder nucleic acids unit as a result of another recent acquisition of the Dowpharma Nucleic Acid business unit. It is expected that up to thirty new hires will be made at the Boulder campus. Bring it!